Curocell
Curocell Inc., a cell gene therapy development company, engages in the development and manufacturing of pharmaceuticals. It provides research and development services; and OVercome Immune Suppression (OVIS), a proprietary platform technology designed to get away from exhaustion induced by immune checkpoint receptors. The company is also involved in the development of CD19 CAR-T treatment, blood c… Read more
Market Cap & Net Worth: Curocell (372320)
Curocell (KQ:372320) has a market capitalization of $458.16 Million (₩670.84 Billion) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #12790 globally and #323 in its home market, demonstrating a -4.21% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Curocell's stock price ₩46650.00 by its total outstanding shares 14380281 (14.38 Million).
Curocell Market Cap History: 2023 to 2026
Curocell's market capitalization history from 2023 to 2026. Data shows growth from $351.60 Million to $458.16 Million (38.43% CAGR).
Index Memberships
Curocell is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.85 Billion | 0.18% | #99 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.85 Billion | 0.18% | #99 of 1384 |
Weight: Curocell's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Curocell Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Curocell's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 372320 by Market Capitalization
Companies near Curocell in the global market cap rankings as of March 19, 2026.
Key companies related to Curocell by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Curocell Historical Marketcap From 2023 to 2026
Between 2023 and today, Curocell's market cap moved from $351.60 Million to $ 458.16 Million, with a yearly change of 38.43%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩458.16 Million | +3.78% |
| 2025 | ₩441.46 Million | +44.77% |
| 2024 | ₩304.95 Million | -13.27% |
| 2023 | ₩351.60 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Curocell was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $458.16 Million USD |
| MoneyControl | $458.16 Million USD |
| MarketWatch | $458.16 Million USD |
| marketcap.company | $458.16 Million USD |
| Reuters | $458.16 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.